Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2
about
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2
description
im Juni 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 07 June 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2018
@uk
name
Sustained efficacy and detaile ...... hase 3 results from RESONATE-2
@en
Sustained efficacy and detaile ...... hase 3 results from RESONATE-2
@nl
type
label
Sustained efficacy and detaile ...... hase 3 results from RESONATE-2
@en
Sustained efficacy and detaile ...... hase 3 results from RESONATE-2
@nl
prefLabel
Sustained efficacy and detaile ...... hase 3 results from RESONATE-2
@en
Sustained efficacy and detaile ...... hase 3 results from RESONATE-2
@nl
P2093
P2860
P50
P1433
P1476
Sustained efficacy and detaile ...... hase 3 results from RESONATE-2
@en
P2093
Alessandra Tedeschi
Carol Moreno
Carolyn Owen
Cathy Zhou
Danelle James
David Simpson
Fritz Offner
Helen McCarthy
Jan A Burger
Jianyong Li
P2860
P304
P356
10.3324/HAEMATOL.2018.192328
P407
P577
2018-06-07T00:00:00Z